|
6505NCM093961
|
6505-01-578-5700
|
Us Erythromycin Stearate Tablets |
Defense Medical Standardization
|
|
Quote
|
|
14474
|
6505-01-578-5700
|
Us Erythromycin Stearate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC55289-0112-40
|
6505-01-578-5700
|
Us Erythromycin Stearate Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
6505NCM093961
|
6505-01-578-5700
|
Us Erythromycin Stearate Tablets |
Defense Medical Standardization
|
|
Quote
|
|
14474
|
6505-01-578-5700
|
Us Erythromycin Stearate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC55289-0112-40
|
6505-01-578-5700
|
Us Erythromycin Stearate Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
6505NCM093980
|
6505-01-578-5947
|
Usp Lisinopril Tablets |
Defense Medical Standardization
|
|
Quote
|
|
14596
|
6505-01-578-5947
|
Usp Lisinopril Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC55289-0696-90
|
6505-01-578-5947
|
Usp Lisinopril Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC00904-5809-89
|
6505-01-578-5947
|
Usp Lisinopril Tablets |
The Harvard Drug Group L.l.c.,
|
|
Quote
|
|
6505NCM093980
|
6505-01-578-5947
|
Usp Lisinopril Tablets |
Defense Medical Standardization
|
|
Quote
|
|
14596
|
6505-01-578-5947
|
Usp Lisinopril Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC55289-0696-90
|
6505-01-578-5947
|
Usp Lisinopril Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC00904-5809-89
|
6505-01-578-5947
|
Usp Lisinopril Tablets |
The Harvard Drug Group L.l.c.,
|
|
Quote
|
|
NDC66267-0653-90
|
6505-01-578-5988
|
Usp Loratadine Tablets |
Nucare Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC00904-5728-89
|
6505-01-578-5988
|
Usp Loratadine Tablets |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC66267-0653-90
|
6505-01-578-5988
|
Usp Loratadine Tablets |
Nucare Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC00904-5728-89
|
6505-01-578-5988
|
Usp Loratadine Tablets |
Major Pharmaceuticals Inc
|
|
Quote
|
|
NDC66267-0653-90
|
6505-01-578-5988
|
Usp Loratadine Tablets |
Nucare Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC00904-5728-89
|
6505-01-578-5988
|
Usp Loratadine Tablets |
Major Pharmaceuticals Inc
|
|
Quote
|
|
6505NCM093984
|
6505-01-578-6005
|
Terbinafine Hydrochloride Tablet |
Defense Medical Standardization
|
|
Quote
|
|
14603
|
6505-01-578-6005
|
Terbinafine Hydrochloride Tablet |
Defense Logistics Agency
|
|
Quote
|
|
NDC55289-0054-42
|
6505-01-578-6005
|
Terbinafine Hydrochloride Tablet |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
6505NCM093984
|
6505-01-578-6005
|
Terbinafine Hydrochloride Tablet |
Defense Medical Standardization
|
|
Quote
|
|
14603
|
6505-01-578-6005
|
Terbinafine Hydrochloride Tablet |
Defense Logistics Agency
|
|
Quote
|
|
NDC55289-0054-42
|
6505-01-578-6005
|
Terbinafine Hydrochloride Tablet |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
6505NCM093984
|
6505-01-578-6005
|
Terbinafine Hydrochloride Tablet |
Defense Medical Standardization
|
|
Quote
|
|
14603
|
6505-01-578-6005
|
Terbinafine Hydrochloride Tablet |
Defense Logistics Agency
|
|
Quote
|
|
NDC55289-0054-42
|
6505-01-578-6005
|
Terbinafine Hydrochloride Tablet |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
6505NCM093984
|
6505-01-578-6005
|
Terbinafine Hydrochloride Tablet |
Defense Medical Standardization
|
|
Quote
|
|
14603
|
6505-01-578-6005
|
Terbinafine Hydrochloride Tablet |
Defense Logistics Agency
|
|
Quote
|
|
NDC55289-0054-42
|
6505-01-578-6005
|
Terbinafine Hydrochloride Tablet |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
6505NCM093985
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Medical Standardization
|
|
Quote
|
|
14604
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC63323-0373-02
|
6505-01-578-6170
|
Usp Ondansetron Injection |
American Pharmaceutical Partners
|
|
Quote
|
|
NDC00703-7221-04
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC00409-4755-03
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Hospira, Inc.
|
|
Quote
|
|
6505NCM093985
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Medical Standardization
|
|
Quote
|
|
14604
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC63323-0373-02
|
6505-01-578-6170
|
Usp Ondansetron Injection |
American Pharmaceutical Partners
|
|
Quote
|
|
NDC00703-7221-04
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC00409-4755-03
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Hospira, Inc.
|
|
Quote
|
|
6505NCM093985
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Medical Standardization
|
|
Quote
|
|
14604
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC63323-0373-02
|
6505-01-578-6170
|
Usp Ondansetron Injection |
American Pharmaceutical Partners
|
|
Quote
|
|
NDC00703-7221-04
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC00409-4755-03
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Hospira, Inc.
|
|
Quote
|
|
6505NCM093985
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Medical Standardization
|
|
Quote
|
|
14604
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC63323-0373-02
|
6505-01-578-6170
|
Usp Ondansetron Injection |
American Pharmaceutical Partners
|
|
Quote
|
|
NDC00703-7221-04
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC00409-4755-03
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Hospira, Inc.
|
|
Quote
|
|
6505NCM093985
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Medical Standardization
|
|
Quote
|
|
14604
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC63323-0373-02
|
6505-01-578-6170
|
Usp Ondansetron Injection |
American Pharmaceutical Partners
|
|
Quote
|
|
NDC00703-7221-04
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC00409-4755-03
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Hospira, Inc.
|
|
Quote
|
|
6505NCM093985
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Medical Standardization
|
|
Quote
|
|
14604
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC63323-0373-02
|
6505-01-578-6170
|
Usp Ondansetron Injection |
American Pharmaceutical Partners
|
|
Quote
|
|
NDC00703-7221-04
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC00409-4755-03
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Hospira, Inc.
|
|
Quote
|
|
6505NCM093985
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Medical Standardization
|
|
Quote
|
|
14604
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Defense Logistics Agency
|
|
Quote
|
|
NDC63323-0373-02
|
6505-01-578-6170
|
Usp Ondansetron Injection |
American Pharmaceutical Partners
|
|
Quote
|
|
NDC00703-7221-04
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Teva Pharmaceuticals Usa, Inc.
|
|
Quote
|
|
NDC00409-4755-03
|
6505-01-578-6170
|
Usp Ondansetron Injection |
Hospira, Inc.
|
|
Quote
|
|
SGLNUUNLL
|
6505-01-578-6339
|
Rehydration Salts For Oral Solut |
Nuun & Co
|
|
Quote
|
|
SGLNUUNLL
|
6505-01-578-6339
|
Rehydration Salts For Oral Solut |
Nuun & Co
|
|
Quote
|
|
SGLNUUNLL
|
6505-01-578-6339
|
Rehydration Salts For Oral Solut |
Nuun & Co
|
|
Quote
|
|
SGLNUUNLL
|
6505-01-578-6339
|
Rehydration Salts For Oral Solut |
Nuun & Co
|
|
Quote
|
|
SGLNUUNLL
|
6505-01-578-6339
|
Rehydration Salts For Oral Solut |
Nuun & Co
|
|
Quote
|
|
SGLNUUNLL
|
6505-01-578-6339
|
Rehydration Salts For Oral Solut |
Nuun & Co
|
|
Quote
|
|
SGLNUUNLL
|
6505-01-578-6339
|
Rehydration Salts For Oral Solut |
Nuun & Co
|
|
Quote
|
|
6505NCM093960
|
6505-01-578-6401
|
Doxazosin Mesylate Tablets |
Defense Medical Standardization
|
|
Quote
|
|
14473
|
6505-01-578-6401
|
Doxazosin Mesylate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC55289-0600-90
|
6505-01-578-6401
|
Doxazosin Mesylate Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
6505NCM093960
|
6505-01-578-6401
|
Doxazosin Mesylate Tablets |
Defense Medical Standardization
|
|
Quote
|
|
14473
|
6505-01-578-6401
|
Doxazosin Mesylate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC55289-0600-90
|
6505-01-578-6401
|
Doxazosin Mesylate Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
6505NCM093960
|
6505-01-578-6401
|
Doxazosin Mesylate Tablets |
Defense Medical Standardization
|
|
Quote
|
|
14473
|
6505-01-578-6401
|
Doxazosin Mesylate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC55289-0600-90
|
6505-01-578-6401
|
Doxazosin Mesylate Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
6505NCM093960
|
6505-01-578-6401
|
Doxazosin Mesylate Tablets |
Defense Medical Standardization
|
|
Quote
|
|
14473
|
6505-01-578-6401
|
Doxazosin Mesylate Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC55289-0600-90
|
6505-01-578-6401
|
Doxazosin Mesylate Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
ACTIQ
|
6505-01-578-9755
|
Fentanyl Citrate Transmucosal Lo |
Cephalon Inc.
|
|
Quote
|
|
6505NCM093987
|
6505-01-578-9755
|
Fentanyl Citrate Transmucosal Lo |
Defense Medical Standardization
|
|
Quote
|
|
14645
|
6505-01-578-9755
|
Fentanyl Citrate Transmucosal Lo |
Defense Logistics Agency
|
|
Quote
|
|
NDC55253-0073-30
|
6505-01-578-9755
|
Fentanyl Citrate Transmucosal Lo |
Watson Labs Inc
|
|
Quote
|
|
NDC63459-0508-30
|
6505-01-578-9755
|
Fentanyl Citrate Transmucosal Lo |
Cephalon Inc.
|
|
Quote
|
|
NDC00406-9208-30
|
6505-01-578-9755
|
Fentanyl Citrate Transmucosal Lo |
Mallinckrodt Llc
|
|
Quote
|
|
M8275058/10
|
6505-01-579-0342
|
Canister |
Kinetic Concepts, Inc.
|
|
Quote
|
|
M8275058/10
|
6505-01-579-0342
|
Canister |
Laboratoire Kci Medical
|
|
Quote
|
|
M8275058/10.S
|
6505-01-579-0342
|
Canister |
Laboratoire Kci Medical
|
|
Quote
|
|
780101
|
6505-01-579-1617
|
For Inje Rho (d) Immune Globulin |
Ortho-clinical Diagnostics, Inc.
|
|
Quote
|
|
2918035
|
6505-01-579-2322
|
Impregna Sodium Chloride Tablets |
Tsi, Incorporated
|
|
Quote
|
|
2918035
|
6505-01-579-2322
|
Impregna Sodium Chloride Tablets |
Tsi, Incorporated
|
|
Quote
|
|
TYLENOL ARTHRITIS
|
6505-01-579-4272
|
Extended-release C Acetaminophen |
Johnson & Johnson Consumer Inc.
|
|
Quote
|
|
6505NCM093988
|
6505-01-579-4272
|
Extended-release C Acetaminophen |
Defense Medical Standardization
|
|
Quote
|
|
14648
|
6505-01-579-4272
|
Extended-release C Acetaminophen |
Defense Logistics Agency
|
|
Quote
|
|
NDC50580-0112-24
|
6505-01-579-4272
|
Extended-release C Acetaminophen |
Johnson & Johnson Consumer Inc.
|
|
Quote
|
|
CALCIUM DISODIUM VERSENATE
|
6505-01-579-4869
|
Edetate Calcium Disodium Injecti |
Graceway Pharmaceuticals Llc
|
|
Quote
|
|
6505NCM094054
|
6505-01-579-4869
|
Edetate Calcium Disodium Injecti |
Defense Medical Standardization
|
|
Quote
|
|
14923
|
6505-01-579-4869
|
Edetate Calcium Disodium Injecti |
Defense Logistics Agency
|
|
Quote
|
|
NDC29336-0400-10
|
6505-01-579-4869
|
Edetate Calcium Disodium Injecti |
Graceway Pharmaceuticals Llc
|
|
Quote
|
|
NDC99207-0240-10
|
6505-01-579-4869
|
Edetate Calcium Disodium Injecti |
Medicis Pharmaceutical Corporation
|
|
Quote
|
|
6505NCM094054
|
6505-01-579-4869
|
Edetate Calcium Disodium Injecti |
Defense Medical Standardization
|
|
Quote
|
|
14923
|
6505-01-579-4869
|
Edetate Calcium Disodium Injecti |
Defense Logistics Agency
|
|
Quote
|
|
NDC99207-0240-10
|
6505-01-579-4869
|
Edetate Calcium Disodium Injecti |
Medicis Pharmaceutical Corporation
|
|
Quote
|
|
6505NCM094006
|
6505-01-579-5486
|
Lidocaine Hydrochloride And Epin |
Defense Medical Standardization
|
|
Quote
|
|
14738
|
6505-01-579-5486
|
Lidocaine Hydrochloride And Epin |
Defense Logistics Agency
|
|
Quote
|
|
NDC00409-7263-01
|
6505-01-579-5486
|
Lidocaine Hydrochloride And Epin |
Hospira, Inc.
|
|
Quote
|
|
NDC 24208-299-05
|
6505-01-579-6087
|
Loteprednol Etaponate |
Bausch & Lomb Pharmaceuticals
|
|
Quote
|
|
0210-01-12
|
6505-01-579-8644
|
Potassium Iodide Oral Solution |
Fleming and Co
|
|
Quote
|
|
THYROSHIELD
|
6505-01-579-8644
|
Potassium Iodide Oral Solution |
Fleming and Co
|
|
Quote
|
|
6505NCM094018
|
6505-01-579-8644
|
Potassium Iodide Oral Solution |
Defense Medical Standardization
|
|
Quote
|
|
14755
|
6505-01-579-8644
|
Potassium Iodide Oral Solution |
Defense Logistics Agency
|
|
Quote
|
|
NDC00256-0210-01
|
6505-01-579-8644
|
Potassium Iodide Oral Solution |
Fleming and Co
|
|
Quote
|
|
6505NCM094022
|
6505-01-579-9449
|
Oseltamivir Phosphate Capsules |
Defense Medical Standardization
|
|
Quote
|
|
14761
|
6505-01-579-9449
|
Oseltamivir Phosphate Capsules |
Defense Logistics Agency
|
|
Quote
|
|
NDC00004-0801-08
|
6505-01-579-9449
|
Oseltamivir Phosphate Capsules |
Roche Laboratories Inc.
|
|
Quote
|
|
6505NCM094021
|
6505-01-579-9697
|
Oseltamivir Phosphate Capsules |
Defense Medical Standardization
|
|
Quote
|
|
TAMIFLU PEDIATRIC
|
6505-01-579-9697
|
Oseltamivir Phosphate Capsules |
Roche Laboratories Inc.
|
|
Quote
|
|
14760
|
6505-01-579-9697
|
Oseltamivir Phosphate Capsules |
Defense Logistics Agency
|
|
Quote
|
|
NDC00004-0802-08
|
6505-01-579-9697
|
Oseltamivir Phosphate Capsules |
Roche Laboratories Inc.
|
|
Quote
|
|
6505NCM094021
|
6505-01-579-9697
|
Oseltamivir Phosphate Capsules |
Defense Medical Standardization
|
|
Quote
|
|
TAMIFLU PEDIATRIC
|
6505-01-579-9697
|
Oseltamivir Phosphate Capsules |
Roche Laboratories Inc.
|
|
Quote
|
|
14760
|
6505-01-579-9697
|
Oseltamivir Phosphate Capsules |
Defense Logistics Agency
|
|
Quote
|
|
NDC00004-0802-08
|
6505-01-579-9697
|
Oseltamivir Phosphate Capsules |
Roche Laboratories Inc.
|
|
Quote
|
|
F7524-100ML
|
6505-01-580-1024
|
Bovine Serum |
Sigma Chemical Co
|
|
Quote
|
|
F7524-100ML
|
6505-01-580-1024
|
Bovine Serum |
Sigma Chemical Co
|
|
Quote
|
|
F7524-100ML
|
6505-01-580-1024
|
Bovine Serum |
Sigma Chemical Co
|
|
Quote
|
|
F7524-100ML
|
6505-01-580-1024
|
Bovine Serum |
Sigma Chemical Co
|
|
Quote
|
|
6505NCM094084
|
6505-01-580-3041
|
Usp Lorazepam Tablets |
Defense Medical Standardization
|
|
Quote
|
|
14983
|
6505-01-580-3041
|
Usp Lorazepam Tablets |
Defense Logistics Agency
|
|
Quote
|
|
NDC05910-0240-05
|
6505-01-580-3041
|
Usp Lorazepam Tablets |
Watson Pharma Inc
|
|
Quote
|
|
6505NCM094110
|
6505-01-580-3505
|
Imiquimod Cream |
Defense Medical Standardization
|
|
Quote
|
|
NDC45802-0368-62
|
6505-01-580-3505
|
Imiquimod Cream |
Perrigo Company
|
|
Quote
|
|
NDC51672-4145-06
|
6505-01-580-3505
|
Imiquimod Cream |
Taro Pharmaceuticals U.s.a., Inc.
|
|
Quote
|
|
120992
|
6505-01-580-8193
|
Usp Theophylline |
Analis Sa
|
|
Quote
|
|
446425
|
6505-01-580-8193
|
Usp Theophylline |
Beckman Coulter, Inc.
|
|
Quote
|
|
1003009
|
6505-01-580-8531
|
Acetaminophen Usp |
United States Pharmacopeial
|
|
Quote
|
|
135725
|
6505-01-580-8947
|
Valproic Acid |
Analis Sa
|
|
Quote
|
|
446430
|
6505-01-580-8947
|
Valproic Acid |
Beckman Coulter, Inc.
|
|
Quote
|
|
F9553-1MG
|
6505-01-580-9644
|
Farnesylt Inhibitor |
Aldrich Chemical Co Inc Sub of Sigma
|
|
Quote
|
